Personal Investment Portfolio · Started November 2025

Investing in companies that invented their category.

I only buy a company if it's creating a brand new category, growing fast, hard to replace, and small enough that it can still 10x.

Most investors pick stocks based on price movements, tips, or vibes. My framework rejects about 87% of companies that look interesting on the surface. When something passes all four filters — which happens maybe once or twice a year — I invest with conviction and hold for a decade.

The goal isn't to be right often. It's to be very right when it matters.

The Framework

My system for finding the next Salesforce before it becomes obvious.

Imagine you're back in 2005 and someone tells you about this small company called Salesforce. Before Salesforce, companies tracked their customers in spreadsheets and sticky notes. Salesforce didn't just make a better spreadsheet — they invented an entirely new category called CRM software, put it in the cloud, and made themselves the only name anyone thought of when someone said "customer relationship management."

That's a Category Leader. They didn't win a race — they created a new race and made themselves the finish line.

I ask four questions about every company, and all four have to pass:

01
Did they invent the category — or just win in one?

Not "are they a good company in an existing market." Did they create the problem definition itself? Rubrik didn't just make better backup software — they invented "Zero Trust Data Security" as a concept. They own the language. That's worth a lot.

02
Are the numbers real and growing fast?

Revenue growing 30%+ per year, margins above 60%, path to making money. This filters out story stocks with no substance behind them.

03
Is it hard to rip out?

If a company's product is deeply embedded in how a business runs — years of data stored there, employees trained on it, everything connected to it — customers don't leave. That stickiness is the moat that protects the investment for a decade.

04
Can it still go 10x from here?

This is the brutal math filter. Great company does not equal great investment. If a company is already worth $80 billion, it needs to reach $800 billion to 10x. Very few companies ever get there. So I only invest when the company is still small enough that the math is actually possible.

A true opportunity that passes all four filters appears roughly once or twice a year. That's why this portfolio is concentrated, not diversified.

Portfolio · As of June 1, 2026

What I own and why.

Total Cost Basis
$13,468
Current Value
$25,344
Total Return
+88.18%
Total Gain
+$11,875.90
RBRK
+48.89%
Rubrik, Inc. · Zero Trust Data Security · 10-Year Hold
What they invented: Rubrik didn't build better backup software. They created a new category called "Zero Trust Data Security" — the idea that when a company gets hit by ransomware, they can recover without paying the ransom. That's a new problem definition, not a feature improvement. Every competitor now positions against their language.

Why the math works: At roughly $15B today, a 10x makes them $150B — comparable to where established security giants like Palo Alto sit now. That's a realistic destination for a category leader growing 46% per year with 84% gross margins. Q4 FY2026 was their best quarter ever: record net new ARR, free cash flow 10x'd year-over-year.
Entry Date
Nov 24, 2025
Avg Cost / Share
$56.47
Return to Date
+48.89%
DDOG
+136.73%
Datadog, Inc. · Cloud Observability · 5-Year Compounder
What they own: Datadog is the company engineers call when they need to know what's happening inside their software in real time. They invented "cloud observability" and now 56% of their customers use 4 or more of their products — meaning once a company is in, leaving is genuinely painful.

The constraint: At ~$80B market cap, a 10x is structurally impossible from here. Held as a 3–5x compounder, not a 10x bet. No new capital added per framework rules. The framework identified this position at $113/share before it became a consensus pick.
Entry Date
Feb 9, 2026
Avg Cost / Share
$113.47
Return to Date
+136.73%

On the radar:

TEM
Tempus AI · AI-powered clinical intelligence. Claims one of the largest proprietary clinical datasets in the world. Evaluating whether they have invented a new category or are a data-enhanced diagnostics company.
Added May 2026
Evaluating
Abridge · AI medical documentation. Turns physician-patient conversations into structured clinical notes in real time. Private. Monitoring for IPO and entry valuation.
Added May 2026
Private · Watching
Databricks · Data + AI platform. Was the top-rated watchlist candidate for a 10x entry. IPO valuation came in at ~$134B — the sub-$30B entry required for 10x math is gone. Monitoring as a potential 5-year compounder if valuation normalizes post-IPO.
Added Dec 2025 · 10x closed Apr 2026
10x Closed · 5yr TBD
AXON
Axon Enterprise · Public safety technology. Dominant platform in law enforcement — body cameras, evidence management, AI-powered dispatch. 80%+ market share, 125% net revenue retention, $14B in contracted backlog. The 10x math doesn't work at $36B. Evaluated as a 5-year compounder and qualified. Deployment blocked by a portfolio concentration rule, not conviction — waiting for the existing position to normalize before adding a second.
Added Jun 2026
10x Closed · 5yr Qualified
Track Record · Self-Reported

Performance since inception.

Portfolio Return
+88.18%
Nov 24, 2025 – June 1, 2026
S&P 500 Same Period
~+13%
SPY total return · see note below
Position Entry Date Cost Basis Current Value Return
DDOG
Datadog · 53 shares
Feb 9, 2026 $6,014 $14,237 +136.73%
RBRK
Rubrik · 132 shares
Nov 24, 2025 $7,454 $11,098 +48.89%
Total $13,468 $25,344 +88.18%
On the benchmark: The S&P 500 figure shown (~+13%) is an estimate for the blended period Nov 24, 2025 – June 1, 2026 using SPY total return with dividends reinvested, weighted by each position's entry date and cost basis. The exact figure will be confirmed and updated on the next monthly update. February 2026 performance is excluded from the return calculation — approximately $10,200 in new capital was deployed mid-month on Feb 9–23, which distorts any time-weighted return calculation for that month. This is noted transparently rather than hidden.

Important context: This account was started in November 2025 and represents approximately 6 months of live performance. A meaningful track record requires 3–5 years minimum. Performance data is self-reported directly from Charles Schwab brokerage statements and has not been independently verified. Past performance does not predict future results.
Deviation #001 · February 2026
DDOG — Bought ahead of earnings, violating framework entry rules
Framework Violation

What happened: DDOG was purchased on February 9, 2026 — the day before Q4 2025 earnings. The stock moved +16% intraday the following day on a strong print. This looks good in hindsight. It was still wrong by the framework.

Why it was wrong: The framework has no earnings-timing component. Buying ahead of a known catalyst is event-driven speculation layered on top of a thesis — it introduces a short-term price dependency into a long-term conviction. If DDOG belongs in the portfolio, the earnings date is irrelevant to that decision. The correct process is to buy when the framework and valuation align, then hold through all earnings events without reacting to them.

The lesson: A track record that only documents clean decisions isn't honest documentation. This deviation is logged here permanently because the framework worked — the entry was right — but the process was wrong. Those are not the same thing.

How Positions Are Managed

When I sell — and when I don't.

Positions are held through price volatility. Positions are sold when the investment thesis breaks. Those are different things.

Automatic exit

Position drops 60% from entry price. Capital preservation rule. No debate, no re-evaluation — sell immediately.

Mandatory re-score

Position drops 30% from entry. Full four-filter framework re-score required within 48 hours. If any single filter scores below 7.0, sell. If score holds above 8.0 and thesis is intact, hold.

Thesis break

Company loses category leadership. Revenue growth falls below 20% for two consecutive quarters. A competitor displaces them as the default name in the category. Any of these triggers a sell regardless of price.

Never a reason to sell

Price volatility alone. Market-wide selloffs. Short-term underperformance versus the S&P 500. Analyst downgrades unaccompanied by thesis change.

How returns are calculated. Time-weighted return (TWR), which removes the distortion caused by adding new capital mid-period and allows apples-to-apples comparison against the S&P 500 benchmark. Benchmark is SPY total return with dividends reinvested over the identical period. All figures are derived from personal Charles Schwab brokerage statements. Pre-tax returns shown. Monthly statements are maintained and available upon reasonable request.

Path to independent verification. Currently self-reported (2025–2027). A CPA verification letter confirming return calculations against brokerage statements is planned for 2028, estimated cost ~$2,000. Full GIPS-compliant audit to follow if and when seeking to manage capital for others — required for Series 65 / RIA registration.

About

Who I am and why this is public.

I'm a Software Product Manager with 10+ years building enterprise software — the same category of products this portfolio invests in. When a company claims to be "creating a new category," I've been through enough vendor evaluations and product cycles to tell the difference between a genuine category shift and a good marketing story.

This is a personal account, not a fund. The long-term goal is to manage capital for others — with a Series 65 license and an RIA practice — and this public, time-stamped track record is the foundation for that. The uncomfortable months stay on the record. The mistakes stay on the record. That's the point.

Personal investment portfolio documented for educational purposes only. Not investment advice. Not a fund. Not a solicitation. The author is not a registered investment advisor. All framework evaluations are personal subjective assessments — not professional ratings, not third-party assessments, and not a recommendation to buy or sell any security. The author holds positions in all securities listed as active and may buy or sell at any time without notice. Performance data is self-reported from personal Charles Schwab brokerage statements and has not been independently verified by any third party. All positions represent personal opinions that may be incorrect. Past performance does not predict future results. All investing involves risk, including the total loss of principal. This site does not constitute an offer or solicitation in any jurisdiction. Consult a licensed financial professional before making investment decisions.